Copyright Reports & Markets. All rights reserved.

Global Hepatitis B Vaccine (Recombinant) Market Research Report 2021

Request for Sample of this report
Buy now

1 Hepatitis B Vaccine (Recombinant) Market Overview

  • 1.1 Product Overview and Scope of Hepatitis B Vaccine (Recombinant)
  • 1.2 Hepatitis B Vaccine (Recombinant) Segment by Type
    • 1.2.1 Global Hepatitis B Vaccine (Recombinant) Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 10mcg/0.5ml
    • 1.2.3 10mcg/ml
  • 1.3 Hepatitis B Vaccine (Recombinant) Segment by Application
    • 1.3.1 Hepatitis B Vaccine (Recombinant) Sales Comparison by Application: (2021-2027)
    • 1.3.2 Newborn
    • 1.3.3 Adult
  • 1.4 Global Hepatitis B Vaccine (Recombinant) Market Size Estimates and Forecasts
    • 1.4.1 Global Hepatitis B Vaccine (Recombinant) Revenue 2016-2027
    • 1.4.2 Global Hepatitis B Vaccine (Recombinant) Sales 2016-2027
    • 1.4.3 Hepatitis B Vaccine (Recombinant) Market Size by Region: 2016 Versus 2021 Versus 2027

2 Hepatitis B Vaccine (Recombinant) Market Competition by Manufacturers

  • 2.1 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Hepatitis B Vaccine (Recombinant) Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Hepatitis B Vaccine (Recombinant) Manufacturing Sites, Area Served, Product Type
  • 2.5 Hepatitis B Vaccine (Recombinant) Market Competitive Situation and Trends
    • 2.5.1 Hepatitis B Vaccine (Recombinant) Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Hepatitis B Vaccine (Recombinant) Players Market Share by Revenue
    • 2.5.3 Global Hepatitis B Vaccine (Recombinant) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Hepatitis B Vaccine (Recombinant) Retrospective Market Scenario by Region

  • 3.1 Global Hepatitis B Vaccine (Recombinant) Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Hepatitis B Vaccine (Recombinant) Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Hepatitis B Vaccine (Recombinant) Market Facts & Figures by Country
    • 3.3.1 North America Hepatitis B Vaccine (Recombinant) Sales by Country
    • 3.3.2 North America Hepatitis B Vaccine (Recombinant) Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Hepatitis B Vaccine (Recombinant) Market Facts & Figures by Country
    • 3.4.1 Europe Hepatitis B Vaccine (Recombinant) Sales by Country
    • 3.4.2 Europe Hepatitis B Vaccine (Recombinant) Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Hepatitis B Vaccine (Recombinant) Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Hepatitis B Vaccine (Recombinant) Sales by Region
    • 3.5.2 Asia Pacific Hepatitis B Vaccine (Recombinant) Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Hepatitis B Vaccine (Recombinant) Market Facts & Figures by Country
    • 3.6.1 Latin America Hepatitis B Vaccine (Recombinant) Sales by Country
    • 3.6.2 Latin America Hepatitis B Vaccine (Recombinant) Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Hepatitis B Vaccine (Recombinant) Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales by Country
    • 3.7.2 Middle East and Africa Hepatitis B Vaccine (Recombinant) Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Hepatitis B Vaccine (Recombinant) Historic Market Analysis by Type

  • 4.1 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2016-2021)
  • 4.2 Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Type (2016-2021)
  • 4.3 Global Hepatitis B Vaccine (Recombinant) Price by Type (2016-2021)

5 Global Hepatitis B Vaccine (Recombinant) Historic Market Analysis by Application

  • 5.1 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2016-2021)
  • 5.2 Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Application (2016-2021)
  • 5.3 Global Hepatitis B Vaccine (Recombinant) Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 GSK
    • 6.1.1 GSK Corporation Information
    • 6.1.2 GSK Description and Business Overview
    • 6.1.3 GSK Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 GSK Product Portfolio
    • 6.1.5 GSK Recent Developments/Updates
  • 6.2 Merck
    • 6.2.1 Merck Corporation Information
    • 6.2.2 Merck Description and Business Overview
    • 6.2.3 Merck Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Merck Product Portfolio
    • 6.2.5 Merck Recent Developments/Updates
  • 6.3 Sanofi Pasteur
    • 6.3.1 Sanofi Pasteur Corporation Information
    • 6.3.2 Sanofi Pasteur Description and Business Overview
    • 6.3.3 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Sanofi Pasteur Product Portfolio
    • 6.3.5 Sanofi Pasteur Recent Developments/Updates
  • 6.4 Dynavax Technologies
    • 6.4.1 Dynavax Technologies Corporation Information
    • 6.4.2 Dynavax Technologies Description and Business Overview
    • 6.4.3 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Dynavax Technologies Product Portfolio
    • 6.4.5 Dynavax Technologies Recent Developments/Updates
  • 6.5 LG Life Sciences
    • 6.5.1 LG Life Sciences Corporation Information
    • 6.5.2 LG Life Sciences Description and Business Overview
    • 6.5.3 LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 LG Life Sciences Product Portfolio
    • 6.5.5 LG Life Sciences Recent Developments/Updates
  • 6.6 KM Biologics
    • 6.6.1 KM Biologics Corporation Information
    • 6.6.2 KM Biologics Description and Business Overview
    • 6.6.3 KM Biologics Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 KM Biologics Product Portfolio
    • 6.6.5 KM Biologics Recent Developments/Updates
  • 6.7 Shenzhen Kangtai Biological Products
    • 6.6.1 Shenzhen Kangtai Biological Products Corporation Information
    • 6.6.2 Shenzhen Kangtai Biological Products Description and Business Overview
    • 6.6.3 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Shenzhen Kangtai Biological Products Product Portfolio
    • 6.7.5 Shenzhen Kangtai Biological Products Recent Developments/Updates
  • 6.8 Serum Institute
    • 6.8.1 Serum Institute Corporation Information
    • 6.8.2 Serum Institute Description and Business Overview
    • 6.8.3 Serum Institute Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Serum Institute Product Portfolio
    • 6.8.5 Serum Institute Recent Developments/Updates

7 Hepatitis B Vaccine (Recombinant) Manufacturing Cost Analysis

  • 7.1 Hepatitis B Vaccine (Recombinant) Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Hepatitis B Vaccine (Recombinant)
  • 7.4 Hepatitis B Vaccine (Recombinant) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Hepatitis B Vaccine (Recombinant) Distributors List
  • 8.3 Hepatitis B Vaccine (Recombinant) Customers

9 Hepatitis B Vaccine (Recombinant) Market Dynamics

  • 9.1 Hepatitis B Vaccine (Recombinant) Industry Trends
  • 9.2 Hepatitis B Vaccine (Recombinant) Growth Drivers
  • 9.3 Hepatitis B Vaccine (Recombinant) Market Challenges
  • 9.4 Hepatitis B Vaccine (Recombinant) Market Restraints

10 Global Market Forecast

  • 10.1 Hepatitis B Vaccine (Recombinant) Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Hepatitis B Vaccine (Recombinant) by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Hepatitis B Vaccine (Recombinant) by Type (2022-2027)
  • 10.2 Hepatitis B Vaccine (Recombinant) Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Hepatitis B Vaccine (Recombinant) by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Hepatitis B Vaccine (Recombinant) by Application (2022-2027)
  • 10.3 Hepatitis B Vaccine (Recombinant) Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Hepatitis B Vaccine (Recombinant) by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Hepatitis B Vaccine (Recombinant) by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    10mcg/0.5ml
    10mcg/ml

    Segment by Application
    Newborn
    Adult

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    GSK
    Merck
    Sanofi Pasteur
    Dynavax Technologies
    LG Life Sciences
    KM Biologics
    Shenzhen Kangtai Biological Products
    Serum Institute

    Buy now